CT Cardiomegaly vs Tempus ECG-AF
AI Verdict
Choose CT Cardiomegaly if…
Choose CT Cardiomegaly if your facility requires an automated, quantitative solution for rapidly assessing cardiomegaly from existing CT chest images. This command-line software is ideal for environments needing precise linear and area-based cardiothoracic ratio measurements for diagnostic assistance or large-scale data analysis. It integrates well into workflows utilizing Docker containers for efficient processing and reporting.
View CT Cardiomegaly →Choose Tempus ECG-AF if…
Choose Tempus ECG-AF if your clinical practice aims to proactively identify elderly patients at elevated risk of developing new-onset atrial fibrillation within the next year. This AI-based algorithm integrates with existing 12-lead ECG systems to support earlier intervention and follow-up for patients aged 65 or older, without pre-existing AF or certain cardiac devices. Its CMS reimbursement availability also makes it a financially viable option for risk stratification.
View Tempus ECG-AF →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | CT Cardiomegaly | Tempus ECG-AF |
|---|---|---|
| Pricing | Fixed-fee | Contact vendor |
| Deployment | Docker Container (Ubuntu 20.04), command-line software | Software solution, integrated into healthcare facility systems with advanced cardiology algorithms. |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Yes AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Tempus ECG-AFTempus ECG-AF is designed for seamless integration into existing healthcare facility systems and EHRs via APIs, providing results within familiar clinical workflows without a dedicated user interface. In contrast, Innolitics' CT Cardiomegaly is a command-line software, which is inherently less user-friendly for typical clinical users and requires more technical expertise for operation and integration.
Clinical Value
Tempus ECG-AFTempus ECG-AF offers a predictive capability to identify patients at increased risk of developing atrial fibrillation within 12 months, enabling proactive intervention and potentially improving patient outcomes for a serious condition. While CT Cardiomegaly provides valuable quantitative diagnostic assistance for cardiomegaly detection, the predictive nature of Tempus ECG-AF for a future event represents a higher clinical impact in terms of preventative care.
Pricing & Value
Tempus ECG-AFTempus ECG-AF clearly outlines CMS reimbursement availability with specific CPT codes (0764T and 0765T) and a Medicare rate of $128.90, effective January 1, 2025, providing transparency and a clear financial pathway for adoption. Innolitics' CT Cardiomegaly only states 'contact for pricing,' offering no public information on its cost or potential reimbursement.
Enterprise Readiness
Tempus ECG-AFTempus ECG-AF demonstrates strong enterprise readiness through its explicit compatibility with major ECG vendors (GE Medical Systems and Philips Medical Systems) and its design for integration into existing healthcare facility systems via APIs and EHRs. While CT Cardiomegaly is deployed via Docker, Tempus ECG-AF's specific integration capabilities suggest a more seamless fit into complex clinical environments.
Innovation
Tempus ECG-AFTempus ECG-AF demonstrates greater innovation by utilizing AI for predictive analytics, identifying patients at risk of developing new-onset atrial fibrillation within 12 months from a standard ECG. This proactive risk stratification for a future medical event is a more advanced application of AI compared to CT Cardiomegaly's automation of a standard diagnostic measurement.
Support & Docs
Tempus ECG-AFTempus ECG-AF explicitly provides dedicated contact information for its Cardiology Support team, including an email address ([email protected]) and a phone number (800.739.4137), indicating clear channels for technical assistance and inquiries. Innolitics' CT Cardiomegaly does not provide specific product support contact details in the available information, only general contact for the company.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | CT Cardiomegaly | Tempus ECG-AF |
|---|---|---|
| Name | CT Cardiomegaly | Tempus ECG-AF |
| Company | Innolitics | Tempus AI, Inc. |
| Primary Function | Automatically measures cardiothoracic ratio from CT chest images, assisting physicians in cardiomegaly detection with quantitative data. | Analyzes 12-lead ECG recordings to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months. |
| Input Data Type | CT chest images | 12-lead ECG recordings |
| Target Condition/Outcome | Cardiomegaly detection | Identification of patients at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months |
| Target Patient Population | Not specified | Patients aged 65 or older without pre-existing AF, pacemakers, ICDs, or recent cardiac surgery |
Videos
Demos, reviews, and walkthroughs featuring CT Cardiomegaly and Tempus ECG-AF.